Natera Basic EPS 2014-2025 | NTRA

Natera annual/quarterly basic eps history and growth rate from 2014 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
  • Natera basic eps for the quarter ending March 31, 2025 was $-0.50, a 10.71% decline year-over-year.
  • Natera basic eps for the twelve months ending March 31, 2025 was $-1.47, a 52.73% decline year-over-year.
  • Natera annual basic eps for 2024 was $-0.002B, a 59.52% decline from 2023.
  • Natera annual basic eps for 2023 was $-0.004B, a 32.14% decline from 2022.
  • Natera annual basic eps for 2022 was $-0.006B, a 6.91% increase from 2021.
Natera Annual Basic EPS
2024 $-1.53
2023 $-3.78
2022 $-5.57
2021 $-5.21
2020 $-2.84
2019 $-1.79
2018 $-2.22
2017 $-2.58
2016 $-1.95
2015 $-2.68
2014 $-1.07
2013 $-9.66
Natera Quarterly Basic EPS
2025-03-31 $-0.50
2024-12-31 $-0.41
2024-09-30 $-0.26
2024-06-30 $-0.30
2024-03-31 $-0.56
2023-12-31 $-0.63
2023-09-30 $-0.95
2023-06-30 $-0.97
2023-03-31 $-1.23
2022-12-31 $-1.37
2022-09-30 $-1.25
2022-06-30 $-1.50
2022-03-31 $-1.45
2021-12-31 $-1.52
2021-09-30 $-1.63
2021-06-30 $-1.32
2021-03-31 $-0.74
2020-12-31 $-0.92
2020-09-30 $-0.72
2020-06-30 $-0.75
2020-03-31 $-0.45
2019-12-31 $-0.44
2019-09-30 $-0.33
2019-06-30 $-0.48
2019-03-31 $-0.54
2018-12-31 $-0.50
2018-09-30 $-0.49
2018-06-30 $-0.62
2018-03-31 $-0.61
2017-12-31 $-0.88
2017-09-30 $-0.52
2017-06-30 $-0.55
2017-03-31 $-0.63
2016-12-31 $-0.82
2016-09-30 $-0.50
2016-06-30 $-0.46
2016-03-31 $-0.17
2015-12-31 $3.18
2015-09-30 $-0.39
2015-06-30 $-3.58
2015-03-31 $-1.89
2014-12-31
2014-09-30 $0.04
2014-06-30 $-0.11
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $19.106B $1.697B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $135.913B 25.22
CVS Health (CVS) United States $77.267B 9.60
Elevance Health (ELV) United States $63.437B 8.53
Cencora (COR) United States $56.784B 19.75
DiDi Global (DIDIY) China $26.545B 28.20
Labcorp Holdings (LH) United States $21.098B 17.11
BioMerieux (BMXMF) France $15.985B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $14.371B 0.00
Medpace Holdings (MEDP) United States $13.731B 35.52
CochLear (CHEOY) Australia $13.060B 0.00
ICON (ICLR) Ireland $13.042B 12.12
Solventum (SOLV) United States $12.616B 13.35
Revvity (RVTY) United States $11.331B 19.50
Viatris (VTRS) United States $10.845B 3.73
Sonic Healthcare (SKHHY) Australia $8.965B 0.00
Avantor (AVTR) United States $8.872B 12.89
HealthEquity (HQY) United States $8.424B 36.90
Charles River Laboratories (CRL) United States $8.024B 15.72
Caris Life Sciences,�Inc (CAI) United States $7.706B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.059B 29.79
BrightSpring Health Services (BTSG) United States $3.542B 32.50
Sotera Health (SHC) United States $3.225B 18.32
Surgery Partners (SGRY) United States $2.827B 36.77
Organon (OGN) United States $2.553B 2.71
Concentras Parent (CON) United States $2.534B 14.64
Alignment Healthcare (ALHC) United States $2.441B 0.00
GeneDx Holdings (WGS) United States $2.308B 88.90
Progyny (PGNY) United States $1.970B 43.36
GoodRx Holdings (GDRX) United States $1.757B 35.14
PACS (PACS) United States $1.750B 0.00
Premier (PINC) United States $1.738B 13.19
Ardent Health (ARDT) United States $1.503B 6.41
Teladoc Health (TDOC) United States $1.477B 0.00
Establishment Labs Holdings (ESTA) $1.257B 0.00
Pediatrix Medical (MD) United States $1.094B 8.33
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.902B 0.00
QDM (QDMI) Hong Kong, SAR China $0.846B 290.00
AMN Healthcare Services Inc (AMN) United States $0.763B 7.14
CareDx (CDNA) United States $0.725B 11.32
Embecta (EMBC) United States $0.625B 4.21
Nutex Health (NUTX) United States $0.556B 8.41
So-Young (SY) China $0.541B 0.00
InnovAge Holding (INNV) United States $0.524B 0.00
SBC Medicals (SBC) United States $0.516B 0.00
Omada Health (OMDA) $0.495B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.62
LifeMD (LFMD) United States $0.471B 0.00
Sonida Senior Living (SNDA) United States $0.468B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.414B 0.00
Enhabit (EHAB) United States $0.342B 28.17
Oncology Institute (TOI) United States $0.316B 0.00
Performant Healthcare (PHLT) United States $0.287B 0.00
Beauty Health (SKIN) United States $0.231B 0.00
DocGo (DCGO) United States $0.149B 24.33
Pheton Holdings (PTHL) China $0.148B 0.00
Sera Prognostics (SERA) United States $0.109B 0.00
Ascend Wellness Holdings (AAWH) United States $0.081B 0.00
KindlyMD (NAKA) United States $0.067B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Biodesix (BDSX) United States $0.053B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.051B 0.00
ModivCare (MODV) United States $0.046B 0.00
Basel Medical Group (BMGL) Singapore $0.041B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.016B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00